Credit Suisse’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Credit Suisse’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-359	Closed	-$23K	–	4719
2021 Q1	$23K	Sell	359 -190	-35%	-$13.3K	﹤0.01%	4253
2020 Q4	$36K	Buy	+549	New	+$35.8K	﹤0.01%	4276
2019 Q4	–	Sell	-479	Closed	-$41K	–	4401
2019 Q3	$41K	Sell	479 -95	-17%	-$10.1K	﹤0.01%	4052
2019 Q2	$73K	Buy	574 +58	+11%	+$8.35K	﹤0.01%	3972
2019 Q1	$93K	Buy	+516	New	+$74.7K	﹤0.01%	3855
2018 Q3	–	Sell	-512	Closed	-$70K	–	4070
2018 Q2	$70K	Sell	512 -519	-50%	-$71.4K	﹤0.01%	3870
2018 Q1	$142K	Buy	1,031 +361	+54%	+$49.1K	﹤0.01%	3755
2017 Q4	$83K	Sell	670 -662	-50%	-$90.9K	﹤0.01%	3861
2017 Q3	$182K	Buy	1,332 +975	+273%	+$147K	﹤0.01%	3961
2017 Q2	$62K	Buy	357 +12	+3%	+$1.71K	﹤0.01%	3766
2017 Q1	$42K	Sell	345 -469	-58%	-$48.8K	﹤0.01%	3754
2016 Q4	$79K	Sell	814 -4	-0.5%	-$367	﹤0.01%	3983
2016 Q3	$76K	Sell	818 -1,263	-61%	-$127K	﹤0.01%	3966
2016 Q2	$224K	Buy	+2,081	New	+$244K	﹤0.01%	3815
2016 Q1	–	Sell	-1,688	Closed	-$201K	–	4379
2015 Q4	$201K	Sell	1,688 -84	-5%	-$10.8K	﹤0.01%	3886
2015 Q3	$301K	Sell	1,772 -1,264	-42%	-$242K	﹤0.01%	3716
2015 Q2	$588K	Buy	3,036 +2,536	+507%	+$471K	﹤0.01%	3600
2015 Q1	$74K	Sell	500 -147	-23%	-$22.4K	﹤0.01%	4258
2014 Q4	$101K	Sell	647 -846	-57%	-$122K	﹤0.01%	4432
2014 Q3	$214K	Sell	1,493 -894	-37%	-$130K	﹤0.01%	4103
2014 Q2	$312K	Sell	2,387 -646	-21%	-$82K	﹤0.01%	4088
2014 Q1	$371K	Sell	3,033 -1,542	-34%	-$167K	﹤0.01%	3936
2013 Q4	$485K	Buy	4,575 +523	+13%	+$50.7K	﹤0.01%	3793
2013 Q3	$455K	Buy	4,052 +652	+19%	+$74K	﹤0.01%	3550
2013 Q2	$383K	Buy	+3,400	New	+$416K	﹤0.01%	3477

Other funds holding SRGA

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Credit Suisse's SRGA Position: Q2 2021 in Review

Credit Suisse sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2021, closing a stake of 359 shares — an estimated $23K sold.

Credit Suisse first reported a position in SRGA in Q2 2013 and held it in 25 quarters. The position peaked at $588K in Q2 2015. 89 funds tracked by Wall St. Rank hold SRGA as of Q2 2021.

Credit Suisse reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Credit Suisse sold 359 Surgalign Holdings, Inc. Common Stock shares in Q2 2021, an estimated $23K.
Credit Suisse first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 25 quarters.
Credit Suisse's Surgalign Holdings, Inc. Common Stock position peaked at $588K in Q2 2015.
89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2021.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.